Emerald bio nollert_pegs_draft_v4.3
Upcoming SlideShare
Loading in...5
×
 

Emerald bio nollert_pegs_draft_v4.3

on

  • 507 views

Presentation at PEGS2012 Boston, MA

Presentation at PEGS2012 Boston, MA

Statistics

Views

Total Views
507
Views on SlideShare
486
Embed Views
21

Actions

Likes
0
Downloads
1
Comments
0

2 Embeds 21

http://www.linkedin.com 18
https://www.linkedin.com 3

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Emerald bio nollert_pegs_draft_v4.3 Emerald bio nollert_pegs_draft_v4.3 Presentation Transcript

  • Parallel protein purification at the mg scale• Introduction Emerald Bio• Concepts & workflow• Multi-target parallel processing• Automated parallel protein purification Peter Nollert, Ph.D. Chief Technology Officer Emerald Bio pnollert@embios.com May 3, 2012 8th Annual Protein Engineering Summit - PEGS 11/16/2012 Copyright 2012 Slide 1
  • Our Protein X-ray Crystallography Structure Output April 15: 482 SSGCID.org Emerald is depositing 1 new structure every 1.7 days11/16/2012 PEGS 2012 Slide 2
  • SSGCID: the Most ProductiveStructural Genomics Center in 2011 1.5 2.0 2.5 3.0 Resolution (Å)3/20/2012 PEGS 2012
  • MTPP: Multi-Target Parallel Processing >100 structures delivered, >60 ligand bound 13 different targets crystallized MTPP and Quality Average Resolution: 2.3Å Average MolProbity: 94 percentile11/16/2012 PEGS 2012 Slide 4
  • Hundreds of Structures Require Thousands of Proteins 684 vector constructs 220 different proteins purified 9.7g = total protein produced 5g11/16/2012 PEGS 2012 Slide 5
  • MPTT: Multi Target Parallel Processing 16 targets selected 14 targets as protein reagent 9 unique target structures Construct Expression Protein X-ray Structure Crystals Generation Testing Samples 269 131 E.coli 231 Purifications Constructs 132 Baculovirus 6 HEK29311/16/2012 PEGS 2012 6
  • Emerald Bio’s : Protein Resource Operating SystemTARGET SPECIFICPROCEDURE Expression Recombinant SAMPLES & Formulations PurificationDEVELOPMENT Constructs Expression Systems INSIGHT Pure Proteins Genes Protein Crystals Compounds Protein / ligand 3D co-structures Target Info Fragment Based Drug DiscoveryBIOLOGY &CHEMISTRY Ligand Optimization Mechanism of Action Intellectual Property TOOLS Gene Process & Data Opti E-screen Protein Composer Management Matrix Builder Maker™ ™ System Maker 7
  • High-throughput parallel protein purificationwith the Protein MakerApplications: Antibody Purification from up to 1 Liter load • Biomarker discovery (immuno depletion) • Parallel expression and purification testingParallel Protein Chromatography • Carries out up to 24 purifications / run • One step purification or two step purification (up to 12 samples) • Uses standard 1-5 mL chromatography columns in parallel • Unattended operation, up to 4 runs / day • Small (1mL) to large (1L) load volumes 11/16/2012 PEGS 2012 8 US Pat.# 6,818,060
  • Protein Maker: Automated Parallel Protein PurificationThroughput:Multiple targets & variants are Target variation:provided in batches Purification of internal deletion variants; His-taggedApproach: Parallelchromatographic IMAC purification Analysis:of 24 target protein • SDS-PAGE • Crystallization Lysates Eluates Crystals 11/16/2012 PEGS 2012 9
  • Protein Maker: Parallel lysis scouting Problem: Standard lysis buffer may not Example render all protein targets soluble. Sample: Cytochrome P450 Solution: Test 12 different cell-lysis buffers insoluble in standard lysis buffer followed by small scale (1 mL) IMAC Result: of 12 lysis buffers 2 yield purification soluble CYP51A (CHAPS/bOG + 500 mM NaCl) Lyse E.coli Ni-IMAC cells in 12 standard SDS-PAGE Scale-up different elution analysis cell lysis buffers protocolSmith, E., et al. (2011). Acta Cryst.F , 67 (9), 1015-1021 PEGS 2012 10 11/16/2012
  • Protein Resources Operating SystemTARGET SPECIFICPROCEDURE Expression Recombinant SAMPLES & Formulations PurificationDEVELOPMENT Constructs Expression Systems INSIGHT Pure Proteins Genes Protein Crystals Compounds Protein / ligand 3D co-structures Target Info Fragment Based Drug DiscoveryBIOLOGY &CHEMISTRY Ligand Optimization Mechanism of Action Intellectual Property TOOLS Process & Data Opti Gene E-screen Protein Management Matrix Composer Builder Maker 11/16/2012 System Maker 11
  • More Results:• Emerald Bio @ PEGS trade show floor: booth# 62/63• Email: pnollert@embios.com11/16/2012 PEGS 2012 12